Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ijpharm.2007.04.031
DC FieldValue
dc.titlePoly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy
dc.contributor.authorDong, Y.
dc.contributor.authorFeng, S.-S.
dc.date.accessioned2014-10-09T06:58:07Z
dc.date.available2014-10-09T06:58:07Z
dc.date.issued2007-09-05
dc.identifier.citationDong, Y., Feng, S.-S. (2007-09-05). Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. International Journal of Pharmaceutics 342 (1-2) : 208-214. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijpharm.2007.04.031
dc.identifier.issn03785173
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/89819
dc.description.abstractHigh pressure homogenization was employed in the current work to prepare poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles (NPs) for controlled release of paclitaxel. The prepared drug-loaded PLGA NPs were found of spherical shape with a size of 200-300 nm. The drug encapsulation efficiency ranged from 34.8 ± 1.6 to 62.6 ± 7.9% depending on the homogenization pressure and cycles. Paclitaxel was released from the nanoparticles in a biphasic profile with a fast release rate in the first 3 days followed by a slow first-order release. A higher or comparable cytotoxicity against glioma C6 cells was found for the drug formulated in the PLGA NPs in comparison with the free drug Taxol®. Confocal laser scanning microscopy (CLSM) evidenced internalization of the fluorescent coumarin 6-loaded PLGA NPs by the C6 cells. The freeze-dried nanoparticles were found to possess excellent water redispersability. The high pressure homogenization could be applied for large industrial scale production of nanoparticles for drug delivery. © 2007 Elsevier B.V. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ijpharm.2007.04.031
dc.sourceScopus
dc.subjectAnticancer drugs
dc.subjectCancer nanotechnology
dc.subjectChemotherapeutic engineering
dc.subjectNanobiotechnology
dc.subjectNanomedicine
dc.subjectPaclitaxel
dc.typeArticle
dc.contributor.departmentCHEMICAL & BIOMOLECULAR ENGINEERING
dc.description.doi10.1016/j.ijpharm.2007.04.031
dc.description.sourcetitleInternational Journal of Pharmaceutics
dc.description.volume342
dc.description.issue1-2
dc.description.page208-214
dc.description.codenIJPHD
dc.identifier.isiut000249680400026
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.